Nureca

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE0DSF01015
  • NSEID: NURECA
  • BSEID: 543264
INR
236.60
-2.1 (-0.88%)
BSENSE

Jun 18

BSE+NSE Vol: 4.68 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Jeevan Scienti.
QMS Medical
Gaudium IVF
Prevest Denpro
Bilcare
Take Solutions
Nureca
Hemant Surgical
Earkart
Star Imaging
KRM Ayurveda
Why is Nureca Ltd ?
1
Weak Long Term Fundamental Strength with a -143.07% CAGR growth in Operating Profits over the last 5 years
  • The company has been able to generate a Return on Equity (avg) of 5.62% signifying low profitability per unit of shareholders funds
2
With a growth in Net Profit of 348.15%, the company declared Very Positive results in Sep 25
  • The company has declared positive results for the last 3 consecutive quarters
  • PAT(Q) At Rs 3.63 cr has Grown at 5449355549118300160.0% (vs previous 4Q average)
  • NET SALES(Q) Highest at Rs 37.74 cr
  • PBDIT(Q) Highest at Rs 3.28 cr.
3
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 5.91%, its profits have risen by 246.8% ; the PEG ratio of the company is 0.3
4
Rising Promoter Confidence
  • Promoters have increased their stake in the company by 0.64% over the previous quarter and currently hold 64.97% of the company
  • Promoters increasing their stake is a sign of high confidence in the future of the business
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Nureca for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Nureca
-14.89%
0.10
58.93%
Sensex
-5.12%
0.44
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-7.19%
EBIT Growth (5y)
-149.52%
EBIT to Interest (avg)
2.91
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
0.72
Tax Ratio
58.23%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.51%
ROCE (avg)
5.36%
ROE (avg)
4.74%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
110
Industry P/E
93
Price to Book Value
1.26
EV to EBIT
-103.07
EV to EBITDA
187.60
EV to Capital Employed
1.33
EV to Sales
1.28
PEG Ratio
0.70
Dividend Yield
NA
ROCE (Latest)
-1.29%
ROE (Latest)
1.15%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
NET SALES(Latest six months)

At Rs 75.05 cr has Grown at 28.95%

PAT(9M)

Higher at Rs 1.27 Cr

-7What is not working for the Company
PAT(Q)

At Rs -6.09 cr has Fallen at -328.9% (vs previous 4Q average

PBDIT(Q)

Lowest at Rs -5.77 cr.

OPERATING PROFIT TO NET SALES (Q)

Lowest at -16.29%

PBT LESS OI(Q)

Lowest at Rs -6.53 cr.

EPS(Q)

Lowest at Rs -6.38

Loading Valuation Snapshot...
Here's what is working for Nureca
Net Sales - Latest six months
At Rs 75.05 cr has Grown at 28.95%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Here's what is not working for Nureca
Profit After Tax (PAT) - Quarterly
At Rs -6.09 cr has Fallen at -328.9% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 2.66 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Lowest at Rs -5.77 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Lowest at -16.29%
in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -6.53 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Earnings per Share (EPS) - Quarterly
Lowest at Rs -6.38
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)